Dr. Monique Bernard is a Research Director (PhD) at the CNRS, a Deputy Director of the CRMBM, and the co-head of the cardiovascular team. In addition, she has been a member of public advisory committees (in the last ten years), an elected member of the Scientific Committee of the Medical School of Marseille (since 2006), and a member of section 28 (imaging, bioengineering, pharmacology) of the CNRS Comité National from 2012 to 2021, and its President from 2016 to 2021. Her research interests are focused on the study of the metabolic, physiological, and functional alterations that occur in cardiovascular pathologies related to diffuse or localized ischemia (atherosclerosis, diabetic and obesity-related cardiomyopathy, atrial fibrillation, and ischemia during transplantation) both in animal models and humans. Her research uses magnetic resonance techniques, with both spectroscopy (MRS, 31P, 23Na, and 1H) and imaging (MRI) combined, for biochemical analyses and molecular biology methods. The experimental models she studies range from the isolated perfused rodent heart model to in vivo rodent models and to humans.
Dr. Monique Bernard is a Research Director (PhD) at the CNRS, a Deputy Director of the CRMBM, and the co-head of the cardiovascular team. In addition, she has been a member of public advisory committees (in the last ten years), an elected member of the Scientific Committee of the Medical School of Marseille (since 2006), and a member of section 28 (imaging, bioengineering, pharmacology) of the CNRS Comité National from 2012 to 2021, and its President from 2016 to 2021. Her research interests are focused on the study of the metabolic, physiological, and functional alterations that occur in cardiovascular pathologies related to diffuse or localized ischemia (atherosclerosis, diabetic and obesity-related cardiomyopathy, atrial fibrillation, and ischemia during transplantation) both in animal models and humans. Her research uses magnetic resonance techniques, with both spectroscopy (MRS, 31P, 23Na, and 1H) and imaging (MRI) combined, for biochemical analyses and molecular biology methods. The experimental models she studies range from the isolated perfused rodent heart model to in vivo rodent models and to humans.